Evidence map›Paper›PMID 42828672›Full record

ArticleClinical journal of gastroenterology2026

Undifferentiated carcinoma of the pancreas arising from intraductal papillary mucinous neoplasm: a case report.

Nagomi Mankawa, Yuki Yamauchi, Koji Kitamura

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nagomi MankawaKyoto University Hospital, Kyoto, Japan. nagomimankawa@gmail.com.ORCID http://orcid.org/0009-0006-3934-6967
Yuki YamauchiHyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
Koji KitamuraHyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 75-year-old woman was referred for evaluation of a pancreatic cystic lesion. Serum tumor markers were normal. Contrast-enhanced computed tomography revealed a 35 mm cystic lesion in the pancreatic body with a 7 mm enhancing mural nodule. Magnetic resonance imaging showed slight T1 hyperintensity, T2 hypointensity, and diffusion restriction of the nodule. Contrast-enhanced endoscopic ultrasound demonstrated a broad-based mural nodule with a slightly irregular surface, heterogeneous internal echogenicity, and persistent enhancement from the early to late phases. The lesion was preoperatively diagnosed as branch-duct intraductal papillary mucinous neoplasm (IPMN) with high-risk stigmata, and middle pancreatectomy was performed. Histopathological examination showed that the cystic lesion was a gastric-type IPMN. The mural nodule consisted primarily of pleomorphic and spindle-shaped atypical cells in a hyalinized stroma with focal multinucleated giant cells. Transition from adenocarcinoma to undifferentiated carcinoma identified in the superficial layer led to the final diagnosis of spindle cell-type undifferentiated carcinoma arising from IPMN. This rare case suggests that even a small mural nodule in a pancreatic cystic lesion may exhibit histologically aggressive features. However, preoperative diagnosis of undifferentiated carcinoma of the pancreas remains challenging. Therefore, when a mural nodule is detected in a pancreatic cystic lesion, the treatment strategy, including the surgical procedure, should be carefully considered.

Indexed as

intraductal papillary mucinous neoplasm (IPMN)Pleomorphic pancreatic carcinomaUndifferentiated carcinoma

Identifiers

PMID42828672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.